We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
431 hedge funds and large institutions have $5.76B invested in State Street SPDR S&P Biotech ETF in 2018 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 153 increasing their positions, 123 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
49% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 43
24% more repeat investments, than reductions
Existing positions increased: 153 | Existing positions reduced: 123
16% more funds holding in top 10
Funds holding in top 10: 19 → 22 (+3)
12% more capital invested
Capital invested by funds: $5.13B → $5.76B (+$635M)
4.89% more ownership
Funds ownership: 106.36% → 111.25% (+4.9%)
4% more funds holding
Funds holding: 414 → 431 (+17)
28% less call options, than puts
Call options by funds: $1.36B | Put options by funds: $1.9B
Holders
431
Holders Change
+17
Holders Change %
+4.11%
% of All Funds
9.87%
Holding in Top 10
22
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+15.79%
% of All Funds
0.5%
New
64
Increased
153
Reduced
123
Closed
43
Calls
$1.36B
Puts
$1.9B
Net Calls
-$540M
Net Calls Change
+$387M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$188M |
| 2 |
Morgan Stanley
New York
|
+$169M |
| 3 |
AssetMark Inc
Concord,
California
|
+$116M |
| 4 |
Goldman Sachs
New York
|
+$94.8M |
| 5 |
SG Americas Securities
New York
|
+$55.2M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$185M |
| 2 |
Rafferty Asset Management
New York
|
-$98.8M |
| 3 |
Citigroup
New York
|
-$75.4M |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$69.1M |
| 5 |
NM
NWI Management
New York
|
-$52.6M |
